Skip to content
Inciteful Med

The Biology of ADOA: Why the Cells Struggle

Last updated:

Autosomal Dominant Optic Atrophy (ADOA) is caused by a mutation in the OPA1 gene, which disrupts the energy-producing mitochondria in the eye's retinal ganglion cells. This energy failure gradually damages the optic nerve, leading to vision loss that typically begins in childhood.

Key Takeaways

  • • ADOA is primarily caused by mutations in the OPA1 gene, which disrupt the mitochondria that provide energy to eye cells.
  • • The retinal ganglion cells in the optic nerve require massive amounts of energy, making them highly vulnerable to this mitochondrial dysfunction.
  • • Unlike LHON, which causes sudden vision loss in young adults, ADOA typically causes gradual vision loss starting in childhood.
  • • Genetic testing for the OPA1 gene is the gold standard for confirming an ADOA diagnosis.
  • • High-resolution OCT imaging helps doctors distinguish ADOA from other conditions like Normal Tension Glaucoma by showing a specific pattern of cell loss.

Understanding why vision changes occur in Autosomal Dominant Optic Atrophy (ADOA) requires looking deep into the cells of the eye. While the symptoms affect how you see the world, the cause is rooted in a “power failure” within the cells that send visual signals to the brain.

The Biology: A Power Management Issue

At the heart of ADOA is a gene called OPA1. Think of OPA1 as the “power plant manager” for your cells [1][2]. It is responsible for maintaining mitochondria, the tiny structures that produce energy (ATP) [3][4].

  • Mitochondrial Fusion: OPA1 helps mitochondria fuse together to stay healthy and efficient [5][6].
  • The Energy Crisis: When the OPA1 gene has a mutation, it can’t manage the power plants correctly. This leads to fragmented mitochondria that produce less energy and more “exhaust” (oxidative stress) [3][7].
  • Targeting the Optic Nerve: The Retinal Ganglion Cells (RGCs) are the long-distance messengers of the eye. Because they have to send signals all the way to the brain, they require a massive amount of energy [3][4]. When the power supply fails, these cells are the first to struggle and eventually degenerate [3][8].

ADOA vs. Other Conditions

Because ADOA causes the optic nerve to look pale (optic disc pallor), it can sometimes be confused with other conditions. However, clear differences help doctors make the right diagnosis.

ADOA vs. LHON

Leber Hereditary Optic Neuropathy (LHON) is another mitochondrial eye condition, but it behaves very differently:

  • Timing: LHON usually causes sudden, rapid vision loss in young adults (often in their 20s), whereas ADOA is slow and starts in childhood [9][10].
  • Inheritance: LHON is only passed down from mothers (maternal inheritance), while ADOA can be passed down from either parent (autosomal dominant) [10][11].
  • Structural Damage: Imaging (OCT) shows that LHON causes more severe damage to the papillomacular bundle (the central vision nerve fibers) than ADOA does [12].

ADOA vs. Normal Tension Glaucoma (NTG)

Normal Tension Glaucoma is a type of glaucoma where eye pressure is normal, but the nerve is still damaged. It is a common misdiagnosis for ADOA [13].

  • Age of Onset: NTG is typically a disease of older adults, while ADOA begins in children [14][15].
  • Anatomy: In NTG, a structure called the Lamina Cribrosa is often deeper and more curved than in ADOA eyes [16].
  • Color Vision: ADOA causes distinct blue-yellow color deficits, which are much less common in early glaucoma [17][18].

How Doctors Confirm ADOA

To avoid these diagnostic pitfalls, specialists use two primary tools:

  1. Genetic Testing: This is the “gold standard.” Finding a mutation in the OPA1 gene (or occasionally other related genes) confirms the diagnosis [13][19]. You can read more in Decoding Your Diagnosis.
  2. High-Resolution OCT: This imaging allows doctors to see the specific pattern of cell loss. In ADOA, the thinning is most pronounced in the nasal area of the macula and the temporal part of the optic nerve [20][21]. This “fingerprint” helps distinguish it from other types of nerve damage [22].

Frequently Asked Questions

What is the role of the OPA1 gene in ADOA?
The OPA1 gene acts as a manager for the mitochondria, the energy-producing structures in your cells. In ADOA, a mutation in this gene causes the mitochondria to fragment, leading to a loss of energy needed for the optic nerve to function properly.
How is ADOA different from Leber Hereditary Optic Neuropathy (LHON)?
While both are mitochondrial eye conditions, ADOA typically begins slowly in childhood and can be inherited from either parent. In contrast, LHON usually causes sudden, rapid vision loss in young adults and is only inherited from the mother.
Can ADOA be misdiagnosed as glaucoma?
Yes, ADOA is sometimes misdiagnosed as Normal Tension Glaucoma (NTG) because both conditions involve optic nerve damage without high eye pressure. Doctors use differences in the age of onset, specific color vision deficits, and eye imaging (OCT) to tell them apart.
How do doctors confirm an ADOA diagnosis?
Doctors confirm ADOA primarily through genetic testing to look for mutations in the OPA1 gene. They also use high-resolution OCT imaging to check for a specific pattern of cell thinning in the optic nerve and macula.

Questions for Your Doctor

  • • Does the OCT (Optical Coherence Tomography) show the specific 'nasal' thinning pattern in the ganglion cell layer typical of ADOA?
  • • How did you rule out Normal Tension Glaucoma (NTG), and were structural markers like the depth of the Lamina Cribrosa measured?
  • • Is my (or my child’s) inheritance pattern 'autosomal dominant' or 'maternal,' and how does that confirm it is ADOA rather than LHON?
  • • Was the genetic testing comprehensive enough to detect large deletions (Copy Number Variations) in the OPA1 gene?

Questions for You

  • • How quickly did the vision loss occur—did it happen over a few weeks or gradually over several years?
  • • Do you experience more difficulty seeing in the center of your vision while your side vision remains clear?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.

    Ding C, Ndiaye PS, Campbell SR, et al.

    The Journal of clinical investigation 2025; (135(12)).

    PMID: 40344041
  2. 2

    Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.

    Venkatesh A, McKenty T, Ali S, et al.

    Nucleic acid therapeutics 2024; (34(5)):221-233 doi:10.1089/nat.2024.0022.

    PMID: 39264859
  3. 3

    Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.

    Kang EY, Tseng YJ, Peng WH, et al.

    Science advances 2026; (12(8)):eadx7815 doi:10.1126/sciadv.adx7815.

    PMID: 41706861
  4. 4

    Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation.

    Chun BY, Rizzo JF

    Current opinion in ophthalmology 2016; (27(6)):475-480 doi:10.1097/ICU.0000000000000314.

    PMID: 27585216
  5. 5

    OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution.

    Macuada J, Molina-Riquelme I, Vidal G, et al.

    Cell death & disease 2024; (15(11)):870 doi:10.1038/s41419-024-07165-9.

    PMID: 39616197
  6. 6

    OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation.

    Zhang K, Zhang W, Zhang L, et al.

    Journal of translational medicine 2025; (23(1)):471 doi:10.1186/s12967-025-06471-w.

    PMID: 40275276
  7. 7

    Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the OPA1 Gene.

    García-López M, Jiménez-Vicente L, González-Jabardo R, et al.

    International journal of molecular sciences 2024; (25(13)) doi:10.3390/ijms25137240.

    PMID: 39000346
  8. 8

    Mitochondrial Gymnastics in Retinal Cells: A Resilience Mechanism Against Oxidative Stress and Neurodegeneration.

    Mirra S, Marfany G

    Advances in experimental medicine and biology 2019; (1185()):513-517 doi:10.1007/978-3-030-27378-1_84.

    PMID: 31884663
  9. 9

    Mitochondrial optic neuropathies.

    Carelli V, La Morgia C, Yu-Wai-Man P

    Handbook of clinical neurology 2023; (194()):23-42 doi:10.1016/B978-0-12-821751-1.00010-5.

    PMID: 36813316
  10. 10

    [Genetic Causes and Genetic Diagnostic Testing of Inherited Optic Atrophies].

    Wissinger B

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(11)):1235-1241 doi:10.1055/a-0759-2094.

    PMID: 30458563
  11. 11

    The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.

    Zhang AM, Bi R, Hu QX, et al.

    Molecular neurobiology 2017; (54(3)):1622-1630 doi:10.1007/s12035-016-9771-z.

    PMID: 26867657
  12. 12

    Serum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy.

    Rufa A, Plantone D, Bargagli A, et al.

    Brain communications 2025; (7(6)):fcaf446 doi:10.1093/braincomms/fcaf446.

    PMID: 41357352
  13. 13

    [Differential diagnosis of juvenile normal pressure glaucoma].

    Geidel K, Wiedemann P, Unterlauft JD

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(9)):828-831 doi:10.1007/s00347-016-0407-5.

    PMID: 27921132
  14. 14

    Comparison of the clinical and genetic features of autosomal dominant optic atrophy and normal tension glaucoma in young Chinese adults.

    Zhang Y, Sun X, Tian G, Chen Y

    Eye (London, England) 2023; (37(4)):624-630 doi:10.1038/s41433-022-01990-y.

    PMID: 35273349
  15. 15

    Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis.

    Han J, Li Y, You Y, et al.

    BMC ophthalmology 2022; (22(1)):322 doi:10.1186/s12886-022-02546-0.

    PMID: 35883160
  16. 16

    Comparison of Lamina Cribrosa Morphology in Normal Tension Glaucoma and Autosomal-Dominant Optic Atrophy.

    Kim GN, Kim JA, Kim MJ, et al.

    Investigative ophthalmology & visual science 2020; (61(5)):9 doi:10.1167/iovs.61.5.9.

    PMID: 32392317
  17. 17

    [Hereditary Optic Neuropathies].

    Rüther K

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(6)):747-763 doi:10.1055/a-0583-6290.

    PMID: 29490390
  18. 18

    Short Wavelength Automated Perimetry, Standard Automated Perimetry, and Optical Coherence Tomography in Dominant Optic Atrophy.

    Lombardo M, Cusumano A, Mancino R, et al.

    Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071971.

    PMID: 38610740
  19. 19

    Mutation Screening of mtDNA Combined Targeted Exon Sequencing in a Cohort With Suspected Hereditary Optic Neuropathy.

    Li JK, Li W, Gao FJ, et al.

    Translational vision science & technology 2020; (9(8)):11 doi:10.1167/tvst.9.8.11.

    PMID: 32855858
  20. 20

    Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.

    Corajevic N, Larsen M, Rönnbäck C

    Acta ophthalmologica 2018; (96(3)):251-256 doi:10.1111/aos.13588.

    PMID: 29091347
  21. 21

    Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.

    Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024; (45(3)):273-277 doi:10.1097/WNO.0000000000002294.

    PMID: 39805076
  22. 22

    Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry.

    Cesareo M, Ciuffoletti E, Martucci A, et al.

    PloS one 2017; (12(3)):e0174560 doi:10.1371/journal.pone.0174560.

    PMID: 28358911

This page provides educational information about the biology and diagnosis of ADOA. It does not replace professional medical advice from your ophthalmologist or geneticist.

Stay up to date

Get notified when new research about Autosomal dominant optic atrophy, classic form is published.

No spam. Unsubscribe anytime.